{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T08:52:03Z","timestamp":1781599923218,"version":"3.54.5"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Blood-based biomarkers would greatly facilitate the clinical diagnosis of Alzheimer\u2019s disease (AD) as minimally invasive measurements. While several blood biomarkers for AD have emerged, the potential of plasma \u03b2-amyloid (A\u03b2) aggregation seeding activity remains underexplored. In this study, we aim to evaluate the ability of this biomarker to distinguish AD and mild cognitive impairment (MCI) due to AD from cognitively unimpaired (CU) individuals and non-AD dementia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      A total of 549 participants were recruited from Xuanwu Hospital, Capital Medical University, between December 2020 and May 2024. Plasma A\u03b2 aggregation seeding activity was measured using a real-time sonication-based protein misfolding cyclic amplification assay across discovery (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 120: 30 CU, 30 MCI due to AD, 30 AD, 30 non-AD dementia) and validation (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 429: 118 CU, 46 MCI due to AD, 141 AD, 124 non-AD dementia) stages. The diagnostic performance of plasma A\u03b2 aggregation seeding activity as a biomarker was assessed using receiver operating characteristic (ROC) curves.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In the validation stage, plasma A\u03b2 aggregation seeding activity exhibited high diagnostic accuracy with optimal cutoff values (Thioflavin T fluorescence %) of 42.91 for distinguishing AD from CU (area under the ROC curve [AUC] = 0.93, 95% confidence interval [CI]: 0.91\u20130.96), 42.02 for AD from non-AD dementia (AUC = 0.91, 95% CI: 0.88\u20130.94), 43.17 for MCI due to AD from CU (AUC = 0.92, 95% CI: 0.87\u20130.96), and 43.24 for MCI due to AD from non-AD dementia (AUC = 0.90, 95% CI: 0.85\u20130.94). Plasma A\u03b2 seeding activity significantly correlated with cognitive functions (Mini-Mental State Examination scores [MMSE]:\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      <jats:sub>s<\/jats:sub>\n                      = \u22120.68,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001; Clinical Dementia Rating scores [CDR]:\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      <jats:sub>s<\/jats:sub>\n                      = 0.71,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>These findings indicate that plasma A\u03b2 aggregation seeding activity could serve as a promising minimally invasive biomarker for identifying both AD and MCI due to AD. This biomarker potentially facilitates early detection and differential diagnosis of AD at different clinical stages.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000004142","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T08:00:58Z","timestamp":1781596858000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Amyloid beta aggregation seeding activity as a new biomarker for Alzheimer\u2019s disease"],"prefix":"10.1097","author":[{"given":"Yang","family":"Song","sequence":"first","affiliation":[{"name":"Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing 100053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[{"name":"Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing 100053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[{"name":"Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing 100053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuya","family":"Nie","sequence":"additional","affiliation":[{"name":"Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing 100053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibo","family":"Wang","sequence":"additional","affiliation":[{"name":"Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing 100053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghong","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Jia","sequence":"additional","affiliation":[{"name":"Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing 100053, China"},{"name":"Beijing Key Laboratory of Geriatric Cognitive Disorders, Beijing 100053, China"},{"name":"Clinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing 100053, China"},{"name":"Center of Alzheimer\u2019s Disease, Beijing Institute of Brain Disorders, Collaborative Innovation Center for Brain Disorders, Capital Medical University, Beijing 100053, China"},{"name":"Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing 100053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"R1-20260616","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1002\/alz.13809","article-title":"2024 Alzheimer\u2019s disease facts and figures","volume":"20","year":"2024","journal-title":"Alzheimers Dement"},{"key":"R2-20260616","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrn1007","article-title":"Unfolding the role of protein misfolding in neurodegenerative diseases","volume":"4","author":"Soto","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"R3-20260616","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.2174\/1871527313666140917095514","article-title":"Protein misfolding and aggregation in Alzheimer\u2019s disease and type 2 diabetes mellitus","volume":"13","author":"Ashraf","year":"2014","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"R4-20260616","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"key":"R5-20260616","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41583-021-00533-w","article-title":"The probabilistic model of Alzheimer disease: The amyloid hypothesis revised","volume":"23","author":"Frisoni","year":"2022","journal-title":"Nat Rev Neurosci"},{"key":"R6-20260616","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/jamaneurol.2013.1453","article-title":"Mechanisms of protein seeding in neurodegenerative diseases","volume":"70","author":"Walker","year":"2013","journal-title":"JAMA Neurol"},{"key":"R7-20260616","doi-asserted-by":"crossref","first-page":"14488","DOI":"10.1523\/JNEUROSCI.3088-11.2011","article-title":"Soluble Abeta seeds are potent inducers of cerebral beta-amyloid deposition","volume":"31","author":"Langer","year":"2011","journal-title":"J Neurosci"},{"key":"R8-20260616","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1097\/CM9.0000000000003802","article-title":"Protein aggregation in neurodegenerative diseases","volume":"138","author":"Wang","year":"2025","journal-title":"Chin Med J"},{"key":"R9-20260616","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.virusres.2014.12.031","article-title":"Prion-like features of misfolded Abeta and tau aggregates","volume":"207","author":"Morales","year":"2015","journal-title":"Virus Res"},{"key":"R10-20260616","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/0092-8674(93)90635-4","article-title":"Seeding \u201cone-dimensional crystallization\u201d of amyloid: A pathogenic mechanism in Alzheimer\u2019s disease and scrapie?","volume":"73","author":"Jarrett","year":"1993","journal-title":"Cell"},{"key":"R11-20260616","doi-asserted-by":"crossref","first-page":"9758","DOI":"10.1073\/pnas.1218402110","article-title":"Proliferation of amyloid-beta42 aggregates occurs through a secondary nucleation mechanism","volume":"110","author":"Cohen","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"R12-20260616","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/35081095","article-title":"Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding","volume":"411","author":"Saborio","year":"2001","journal-title":"Nature"},{"key":"R13-20260616","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm.2294","article-title":"Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion","volume":"17","author":"Atarashi","year":"2011","journal-title":"Nat Med"},{"key":"R14-20260616","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/mds.28242","article-title":"Blinded RT-QuIC analysis of alpha-synuclein biomarker in skin tissue from Parkinson\u2019s disease patients","volume":"35","author":"Manne","year":"2020","journal-title":"Mov Disord"},{"key":"R15-20260616","first-page":"1","article-title":"Skin alpha-synuclein aggregation seeding activity as a novel biomarker for Parkinson disease","volume":"78","author":"Wang","year":"2020","journal-title":"JAMA Neurol"},{"key":"R16-20260616","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/mds.28976","article-title":"Diagnostic value of salivary real-time quaking-induced conversion in Parkinson\u2019s disease and multiple system atrophy","volume":"37","author":"Luan","year":"2022","journal-title":"Mov Disord"},{"key":"R17-20260616","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/mds.27907","article-title":"alpha-Synuclein real-time quaking-induced conversion in the submandibular glands of Parkinson\u2019s disease patients","volume":"35","author":"Manne","year":"2020","journal-title":"Mov Disord"},{"key":"R18-20260616","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1056\/NEJMoa1315200","article-title":"A test for Creutzfeldt-Jakob disease using nasal brushings","volume":"371","author":"Orru","year":"2014","journal-title":"N Engl J Med"},{"key":"R19-20260616","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1056\/NEJMoa1404401","article-title":"Prions in the urine of patients with variant Creutzfeldt-Jakob disease","volume":"371","author":"Moda","year":"2014","journal-title":"N Engl J Med"},{"key":"R20-20260616","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1001\/jamaneurol.2016.3733","article-title":"Diagnosing sporadic Creutzfeldt-Jakob disease by the detection of abnormal prion protein in patient urine","volume":"73","author":"Luk","year":"2016","journal-title":"JAMA Neurol"},{"key":"R21-20260616","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.celrep.2014.02.031","article-title":"Detection of misfolded Abeta oligomers for sensitive biochemical diagnosis of Alzheimer\u2019s disease","volume":"7","author":"Salvadores","year":"2014","journal-title":"Cell Rep"},{"key":"R22-20260616","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13195-022-00964-2","article-title":"Detection of plasma Abeta seeding activity by a newly developed analyzer for diagnosis of Alzheimer\u2019s disease","volume":"14","author":"Jia","year":"2022","journal-title":"Alzheimers Res Ther"},{"key":"R23-20260616","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1021\/acschemneuro.1c00461","article-title":"Half-time heat map reveals ultrasonic effects on morphology and kinetics of amyloidogenic aggregation reaction","volume":"12","author":"Nakajima","year":"2021","journal-title":"ACS Chem Neurosci"},{"key":"R24-20260616","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/alz.12153","article-title":"The APOE epsilon4 exerts differential effects on familial and other subtypes of Alzheimer\u2019s disease","volume":"16","author":"Jia","year":"2020","journal-title":"Alzheimers Dement"},{"key":"R25-20260616","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1373\/clinchem.2004.039347","article-title":"Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology","volume":"51","author":"Olsson","year":"2005","journal-title":"Clin Chem"},{"key":"R26-20260616","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"R27-20260616","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"R28-20260616","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"key":"R29-20260616","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","article-title":"Classification of primary progressive aphasia and its variants","volume":"76","author":"Gorno-Tempini","year":"2011","journal-title":"Neurology"},{"key":"R30-20260616","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"R31-20260616","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov Disord"},{"key":"R32-20260616","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1074\/jbc.M210207200","article-title":"In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis","volume":"278","author":"Stine","year":"2003","journal-title":"J Biol Chem"},{"key":"R33-20260616","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"R34-20260616","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/nprot.2012.067","article-title":"Protein misfolding cyclic amplification of infectious prions","volume":"7","author":"Morales","year":"2012","journal-title":"Nat Protoc"},{"key":"R35-20260616","doi-asserted-by":"crossref","first-page":"11119","DOI":"10.1073\/pnas.0901422106","article-title":"Ultrasonication-dependent production and breakdown lead to minimum-sized amyloid fibrils","volume":"106","author":"Chatani","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"R36-20260616","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jmb.2011.07.069","article-title":"Ultrasonication-dependent acceleration of amyloid fibril formation","volume":"412","author":"So","year":"2011","journal-title":"J Mol Biol"},{"key":"R37-20260616","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1110\/ps.04831804","article-title":"Sonication of proteins causes formation of aggregates that resemble amyloid","volume":"13","author":"Stathopulos","year":"2004","journal-title":"Protein Sci"},{"key":"R38-20260616","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00249-022-01601-4","article-title":"Ultrasound-induced protein restructuring and ordered aggregation to form amyloid crystals","volume":"51","author":"Pathak","year":"2022","journal-title":"Eur Biophys J"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000004142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T08:01:02Z","timestamp":1781596862000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000004142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":38,"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000004142","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"2025-03-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}